Tag:
AZD3480
Latest Headlines
Latest Headlines
Drug trial news hurts Targacept, not AZ
Following news that Targacept's experimental nicotine drug, AZD3480, was ineffective in schizophrenia patients, AstraZeneca shares fell more than 1 percent yesterday, but Targacept shares dropped
Targacept, AZ dump schizophrenia drug
Targacept and partner AstraZeneca said today that they will not pursue further development of AZD3480 for cognitive dysfunction in schizophrenia patients after the drug failed a mid-stage trial. The
